WuXi Biologics Executive and Leadership Team

Jimmy Li, the Chief Executive Officer at WuXi Biologics, directs the company's overall strategic vision and operational execution. Li guides the enterprise in delivering integrated technology platforms for biologics drug development, ensuring alignment with global market demands and scientific advancements. Overseeing all major business units, Li drives expansion initiatives and fosters key partnerships essential for sustained growth. This leadership role involves navigating complex regulatory landscapes and championing innovation across all research and development pipelines. By focusing on operational excellence, Jimmy Li ensures WuXi Biologics maintains its position as a premier global provider of biologics discovery, development, and manufacturing services, directly impacting the advancement of life-saving therapies worldwide.

Ming Tu, the Chief Financial Officer at WuXi Biologics, manages all financial operations and strategic financial planning for the organization. Tu oversees capital allocation, investment strategies, and financial risk management, ensuring the company's fiscal health and sustainable expansion. This role involves close collaboration with executive leadership to support business objectives through robust financial frameworks. Ming Tu directs treasury functions, investor relations, and accounting operations, providing critical insights that inform corporate decision-making. By optimizing financial performance and securing necessary funding, Tu enables WuXi Biologics to invest in cutting-edge technologies and expand its global service offerings, thereby reinforcing the company's capacity to accelerate biologics drug development for clients worldwide.

Jijie Gu, the President (Global), Biologics Research & Chief Scientific Officer at WuXi Biologics, leads the company's comprehensive biologics research initiatives and scientific strategy on a global scale. Gu directs the scientific direction for drug discovery and development programs, ensuring the application of cutting-edge methodologies and technologies. This leadership position involves fostering a culture of scientific excellence and innovation across all research departments. Jijie Gu oversees the scientific teams responsible for advancing novel biologics candidates from concept through preclinical stages, providing critical expertise that underpins the company's integrated service offerings. By guiding scientific exploration and development, Gu plays a pivotal role in accelerating the journey of new therapies from the laboratory to patients, reinforcing WuXi Biologics' commitment to global health advancements.

Xuejun Gu, the Chief Technology Officer at WuXi Biologics, spearheads the development and implementation of advanced technological solutions across the company's integrated platforms. Gu directs the strategic integration of novel technologies to enhance biologics drug discovery, development, and manufacturing processes, ensuring WuXi Biologics remains at the forefront of biopharmaceutical innovation. This leadership position involves overseeing research into new platform capabilities and optimizing existing systems for efficiency and scalability. Xuejun Gu drives the technological roadmap, focusing on digital transformation and data analytics to accelerate project timelines and improve success rates for clients. By advancing the company's technological infrastructure, Gu directly supports the mission of enabling faster, more efficient development of life-changing biologics.

Sherry Gu, the Executive Vice President & Chief Technology Officer at WuXi Biologics, drives the strategic direction and execution of technological advancements within the company's global operations. Gu oversees the deployment of innovative technologies that enhance the efficiency and scalability of biologics research, development, and manufacturing services. This critical role involves leading cross-functional teams to implement state-of-the-art solutions, ensuring WuXi Biologics maintains its competitive edge in the biopharmaceutical industry. Sherry Gu focuses on optimizing operational workflows through technological integration, thereby accelerating the delivery of high-quality biologics to clients worldwide. By championing technological excellence, Gu directly contributes to the company's mission of enabling the development of novel therapies and improving global health outcomes.